When a neural interface malfunctions and causes injury — cognitive fragmentation, motor override failure, sensory cascade events — the question of legal liability in GLMZ passes through a labyrinth of competing frameworks before arriving at an answer that almost never favors the injured party. The primary statute governing augmentation liability is the Integrated Systems Accountability Act of 2174, which established a tiered liability structure based on the hardware tier of the implant, the certification status of the installation clinic, and whether the malfunction was classified as a 'design defect,' a 'maintenance failure,' or a 'user modification event.' The third category is applied with extraordinary flexibility by manufacturers' legal teams.

For Tier 1 and Tier 2 augmentations — the premium neural interfaces produced by the seven licensed manufacturers, including Axiom Data Systems and NeuroFrame Ltd. — liability claims are handled through the Augmentation Dispute Resolution Panel, a specialized tribunal funded jointly by the manufacturers and the Meridian Civic Authority. The Panel operates under a binding cap: maximum compensation for a malfunction event is 340,000 Quantum Credits, regardless of severity. This cap was set in 2174 and has not been adjusted for inflation, meaning its real value has declined by approximately 60%. For fatal malfunction events, the Panel has an additional provision limiting wrongful death claims by SSA holders to their outstanding debt value — a feature that has attracted sustained criticism from the Lakeview Human Rights Collective.

For Tier 3 and below — gray-market implants, second-hand units, and augmentations installed by uncertified clinics in districts like the Pilsen Corridor and the South Shore Mesh — there is effectively no civil liability pathway. The manufacturers disclaim responsibility for devices sold outside licensed channels, and the installing clinics are often unregistered entities that cannot be named as defendants. Injured individuals in this category can theoretically file with Meridian's General Civil Court, but without a certified implant ID — which gray-market units typically lack — they cannot establish the chain of custody required to prove manufacturer liability. Approximately 73% of augmentation malfunction injuries in GLMZ occur in gray-market contexts, according to the 2199 Regional Health Compliance Report.

A growing area of legal dispute concerns 'remote update liability' — cases in which a manufacturer pushes a firmware update to a live implant that causes a malfunction event. The Integrated Systems Accountability Act was written before remote updates were standard practice, and its language is ambiguous on whether an update constitutes a new 'design event' that resets the liability clock. Axiom Data Systems argued in the 2196 case Mwangi v. Axiom that a fatal sensory cascade event caused by Update 7.3.1 was the user's fault for failing to disable the auto-update feature — a feature that is enabled by default and buried six menus deep in the interface settings. The Augmentation Dispute Resolution Panel agreed.